Cargando…
Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates
The treatment options for cancer patients include surgery, chemotherapeutics, radiation therapy, antibody therapy and various combinations of these therapies. The challenge with each therapy is finding the balance between maximizing the anti-tumor efficacy while minimizing the dose limiting toxiciti...
Autores principales: | Jackson, Dowdy, Stover, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596896/ https://www.ncbi.nlm.nih.gov/pubmed/25339341 http://dx.doi.org/10.1007/s11095-014-1536-7 |
Ejemplares similares
-
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
por: Kamath, Amrita V., et al.
Publicado: (2014) -
Methods to Make Homogenous Antibody Drug Conjugates
por: Kline, Toni, et al.
Publicado: (2014) -
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
por: Shah, Mihir, et al.
Publicado: (2019) -
PET Imaging in Preclinical Anti-Aβ Drug Development
por: Syvänen, Stina, et al.
Publicado: (2022) -
Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation
por: Rodrigues, Gerard A., et al.
Publicado: (2018)